FDA: Healthcare professionals, patients should avoid Cantrell products

Gephardt Daily

“The agency is concerned about serious deficiencies in Cantrell's compoundingoperations, including its processes to ensure quality and sterility assurance that put patient safety at risk,” the FDA said in a release. “Administration